Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis

类风湿性关节炎 单克隆抗体 抗体 免疫学 病毒学 单克隆 医学
作者
Liqing Ke,Qifei He,Jing Qu,Xiyue Wang,Kaibo Li,Xun Gong,Kwang‐Hyun Baek,Jiake Xu,Qiuliyang Yu,Sheng Wang,Lin Xiao,Jia Li,Nguan Soon Tan,Wei Wang,Li Liang,Peng Zhang,Wenxiang Cheng
出处
期刊:Molecular Therapy [Elsevier]
标识
DOI:10.1016/j.ymthe.2024.09.031
摘要

Despite recent advances, rheumatoid arthritis (RA) patients remain refractory to therapy. Dysregulated overproduction of angiopoietin-like 4 protein (ANGPTL4) is thought to be contributed to the disease development. ANGPTL4 was initially identified as a regulator of lipid metabolism, which is hydrolyzed to N-terminal (nANGPTL4) and C-terminal (cANGPTL4) fragments in vivo. cANGPTL4 is involved in several non-lipid-related processes, including angiogenesis and inflammation. The present study revealed that the level of ANGPTL4 was markedly elevated in the sera and synovial tissues from patients with RA versus controls. The administration of a neutralizing antibody against cANGPTL4 (anti-cANGPTL4 Ab) resulted in the inhibition of inflammatory processes and bone loss in animal models of collagen-induced arthritis (CIA) and adjuvant-induced arthritis (AIA). Transcriptomic and proteomic profiling of synovial tissues from AIA model indicated that the anti-cANGPTL4 Ab inhibited fibroblast-like synoviocytes (FLS) immigration and inflammatory-induced osteoclastogenesis. Mechanistically, the anti-cANGPTL4 Ab has been shown to inhibit TNF-α-induced inflammatory cascades in RA-FLS through the sirtuin 1/nuclear factor-κB signaling pathway. Moreover, the anti-cANGPTL4 Ab was found to block FLS invasion- and immigration-induced osteoclast activation. Collectively, these findings identify ANGPTL4 as a prospective biomarker for the diagnosis of RA, and targeting cANGPTL4 may represent a potential therapeutic strategy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
情怀应助晚风采纳,获得10
1秒前
zh关闭了zh文献求助
2秒前
jiudai完成签到 ,获得积分10
3秒前
小李叭叭完成签到,获得积分10
4秒前
双位循环完成签到 ,获得积分10
4秒前
Jasper应助XXXXX采纳,获得10
5秒前
6秒前
6秒前
桥本发布了新的文献求助10
6秒前
成就仇天完成签到 ,获得积分10
7秒前
9秒前
lin应助mabingg采纳,获得10
10秒前
11秒前
15秒前
ding应助Mp4采纳,获得10
15秒前
15秒前
15秒前
15秒前
15秒前
15秒前
16秒前
小妮完成签到 ,获得积分10
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
16秒前
17秒前
17秒前
17秒前
17秒前
17秒前
17秒前
曲微暖完成签到,获得积分20
17秒前
17秒前
高分求助中
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 800
Ethnicities: Media, Health, and Coping 700
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
A Dissection Guide & Atlas to the Rabbit 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3089386
求助须知:如何正确求助?哪些是违规求助? 2741586
关于积分的说明 7565941
捐赠科研通 2392093
什么是DOI,文献DOI怎么找? 1268497
科研通“疑难数据库(出版商)”最低求助积分说明 614069
版权声明 598692